The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...

The women’s health focused company acquired the drug for up to $954 million in 2021 through the acquisition of Forendo Pharma ...

"I’ll always have a chronic disease, but I will not let it define me—it’s just one part of my story." ...

The study, published Tuesday in The Lancet Oncology, focused on women under 55 with and without a uterus. CBS News medical ...

Women who had been exposed to violence in their childhood had a twofold greater likelihood of being diagnosed with ...

Endometriosis is a chronic condition that happens when endometrial-like tissue grows outside the uterus in other parts of the body – the ovaries, fallopian tubes, or the surface of the uterus.

The aging American population contributes to rising cancer rates across all demographics, but additional factors amplify ...

For a condition that affects 10 to 15% of women worldwide, endometriosis research, like most of research about women’s health ...

Organon said on Wednesday it will discontinue the development of its experimental drug, after it failed to reduce pain in women suffering from endometriosis in a mid-stage study.

Dr Bandana Sodhi: Endometriosis is a progressive condition in which tissue similar to the uterine lining grows outside the uterus, resulting in chronic pelvic pain and heavy menstrual bleeding.

The study uncovers how ovarian ECM tropism influences endometriotic cell adhesion, paving the way for novel strategies to ...

New research links endometriosis to autoimmune diseases, revealing shared mechanisms that may lead to earlier diagnosis and ...